What happened
NKGen Biotech Korea's largest shareholder (NKGen Biotech, Inc.) pledged shares as loan collateral, securing up to US$26.4M.
If the collateral is enforced, the largest shareholder's stake, and with it, control of the company, could change.
| Largest shareholder | NKGen Biotech, Inc. |
|---|---|
| Current stake | 64.14% |
| Loan secured | US$26.4M |
| Stake if enforced | 0% |
| Filed | 2026-04-22, [Amended] Share-pledge agreement that may change the largest shareholder |
| Source | DART rcept 20260422900484 → open original filing |
Versions of this filing
- 2026-01-12Original
- 2026-04-22Amendment 1 (this page)
Source: DART. Information only, not investment advice.